Sakowitz Sara, Bakhtiyar Syed Shahyan, Mallick Saad, Vadlakonda Amulya, Chervu Nikhil, Shemin Richard, Benharash Peyman
Cardiovascular Outcomes Research Laboratories (CORELAB), University of California, Los Angeles, Los Angeles, California.
Cardiovascular Outcomes Research Laboratories (CORELAB), University of California, Los Angeles, Los Angeles, California; Department of Surgery, University of Colorado, Aurora, Colorado.
J Heart Lung Transplant. 2025 Jan;44(1):33-43. doi: 10.1016/j.healun.2024.08.012. Epub 2024 Sep 30.
While structural socioeconomic inequity has been linked with inferior health outcomes, some have postulated reduced access to high-quality care to be the mediator. We assessed whether treatment at high-volume centers (HVC) would mitigate the adverse impact of area deprivation on heart transplantation (HT) outcomes.
All HT recipients ≥18 years were identified in the 2005-2022 Organ Procurement and Transplantation Network. Neighborhood socioeconomic deprivation was assessed using the previously validated Area Deprivation Index. Recipients with scores in the highest quintile were considered Most Deprived (others: Less Deprived). Hospitals in the highest quartile by cumulative center volume (≥21 transplants/year) were classified as HVC. The primary outcome was post-transplant survival.
Of 38,022 HT recipients, 7,579 (20%) were considered Most Deprived. Following risk adjustment, Most Deprived demonstrated inferior survival at 3 (hazard ratio [HR] 1.14, 95% confidence interval [CI] 1.06-1.21) and 5 years following transplantation (HR 1.13, CI 1.07-1.20). Similarly, Most Deprived faced greater graft failure at 3 (HR 1.14, CI 1.06-1.22) and 5 years (HR 1.13, CI 1.07-1.20). Evaluating patients transplanted at HVC, Most Deprived continued to face greater mortality at 3 (HR 1.10, CI 1.01-1.21) and 5 years (HR 1.10, CI 1.01-1.19). The interaction between Most Deprived status and care at HVC was not significant, such that transplantation at HVC did not ameliorate the survival disparity between Most and Less Deprived.
Area socioeconomic disadvantage is independently associated with inferior survival. Transplantation at HVC did not eliminate this inequity. Future efforts are needed to increase engagement with longitudinal follow-up care and address systemic root causes to improve outcomes.
虽然结构性社会经济不平等与较差的健康结果有关,但一些人推测获得高质量医疗服务的机会减少是其中介因素。我们评估了在高容量中心(HVC)接受治疗是否会减轻地区贫困对心脏移植(HT)结果的不利影响。
在2005 - 2022年器官获取与移植网络中识别出所有年龄≥18岁的心脏移植受者。使用先前验证的地区贫困指数评估邻里社会经济贫困状况。得分处于最高五分位数的受者被视为最贫困者(其他:较不贫困)。按累计中心移植量(≥21例/年)处于最高四分位数的医院被归类为高容量中心。主要结局是移植后生存率。
在38,022例心脏移植受者中,7,579例(20%)被视为最贫困者。经过风险调整后,最贫困者在移植后3年(风险比[HR] 1.14,95%置信区间[CI] 1.06 - 1.21)和5年时生存率较低(HR 1.13,CI 1.07 - 1.20)。同样,最贫困者在移植后3年(HR 1.14,CI 1.06 - 1.22)和5年时面临更高的移植物失败率(HR 1.13,CI 1.07 - 1.20)。对在高容量中心接受移植的患者进行评估时,最贫困者在移植后3年(HR 1.10,CI 1.01 - 1.21)和5年时仍面临更高的死亡率(HR 1.10,CI 1.01 - 1.19)。最贫困状态与在高容量中心接受治疗之间的交互作用不显著,因此在高容量中心进行移植并未改善最贫困者与较不贫困者之间的生存差异。
地区社会经济劣势与较差的生存率独立相关。在高容量中心进行移植并不能消除这种不平等。未来需要做出努力,加强长期随访护理,并解决系统性根本原因以改善结果。